Cholera vaccine effectiveness in Nsanje and Chikwawa, Malawi (360G-Wellcome-214662_Z_18_Z)
Following the 2015 oral cholera vaccine (OCV) mass campaign of 160,000 people in Nsanje District, Malawi, the International Vaccine Institute (IVI) was funded to setup diarrheal disease surveillance in Nsanje and adjacent Chikwawa districts. Surveillance is ongoing at 22 and 18 health care facilitiesin Nsanje and Chikwawa, respectively. Research activities include to 1) analyse the vaccine effectiveness (VE) in Nsanje, through a 1:4 case-control study and 2) conduct a cost-of-illness study to help estimate OCV cost-effectiveness. The IVI is working in parallel in neighboring Mozambique. Diarrheal disease surveillance is ongoing in the Cuamba study area and an OCV has been conducted in 08/2018. The Mozambique study area borders the Malawian Nsanje/Chikwawa districts. We propose to continue the research in Malawi through extending the surveillance work and the case-control study, to ensure the assessment of long-term VE and cost-effectiveness. Further, the extent of herd protection through OCV needs to be assessed; the Chikwawa setting, after the 2018 OCV campaign constitutes the perfect scenario. The GFTCC is currently preparing a research agenda for "End cholera by 2030" roadmap and the Malawi/Mozambique scenario with surveillance ongoing in both countries, provides an unique opportunity to answer research questions identified through the GFTCC.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 155986 |
Applicant Surname | Marks |
Approval Committee | Internal Decision Panel |
Award Date | 2018-09-30T00:00:00+00:00 |
Financial Year | 2017/18 |
Grant Programme: Title | DFID-Wellcome Epidemic Preparedness Grant |
Internal ID | 214662/Z/18/Z |
Lead Applicant | Dr Florian Marks |
Partnership Name | Wellcome-DFID Epidemic Preparedness |
Partnership Value | 311974 |
Planned Dates: End Date | 2021-03-31T00:00:00+00:00 |
Planned Dates: Start Date | 2018-09-30T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | East of England |